EU taxonomy forest bioenergy inclusion ‘unlawful’
Seven NGOs have filed an annulment action with the European Commission
Litigation
-
-
Pharmaceuticals remain a draw for ESG investors
EdenTree’s Patel says industry’s response to Covid and innovation keep it attractive to ESG investors
-
Climate litigation: The growing risk for companies
Schroders’ Simon Webber and Isabella Hervey-Bathurst are looking for climate leaders to mitigate this risk
-
Healthcare scores poorly for ESG but is a vital sector
Access to medicine as well as litigation and reputation risks make it a complex area for sustainable investors
-
Healthcare scores poorly for ESG but is a vital sector
Access to medicine as well as litigation and reputation risks make it a complex area for sustainable investors
-
Sector special: Healthcare poses challenges for ESG investors
Access to medicine as well as litigation risks and reputation make it a complex area
-
Lawsuits over greenwashing and data privacy could rise
Currently, litigation risks are often reputational, but greenwashing claims could rise as disclosure requirements increase
-
Fossil fuel windfall has no part in a just transition
There needs to be a penalty for the industry that has been the greatest sole contributor to climate change
-
‘No dishonesty’ in green label for gas and nuclear
Those preparing to legally challenge taxonomy say it now breaks its own rules
-
Investors warned using gas and nuclear is ‘greenwashing’ despite EU taxonomy guidelines
UK lawmakers encouraged to learn from furore and exclude polluting energy sources from its own labelling system
-
Investing in hard-to-measure climate solutions
We cannot tackle climate change without leveraging carbon markets and channeling funding into climate not-for-profits
-
Dutch activists promise ‘unrelenting pressure’ for climate laggards
Companies given until April to produce ambitious climate strategies